However, it does not appear that FGF2 alone is crucial to the efficacy of 5-ALA-PDT as FGF2 added to U-105MG glioma cells did not have a stimulating or inhibitory effect on the final treatment outcomes [156]. Here, FGF2 is linked to central nervous system cancer.